Literature DB >> 27193875

Effect of chronic fluoxetine treatment on audiogenic epilepsy, symptoms of anxiety and depression in rats of four lines.

K Yu Sarkissova1, I B Fedotova2, N M Surina2, G M Nikolaev2, O V Perepelkina2, I I Poletaeva3.   

Abstract

Anxiety (Anx) and depression (Dp) levels were evaluated in rats of 4 lines: 2 of them (KM and "4") exhibited audiogenic seizures (AS), and 2 (Wistar and "0") had no AS. In KM rats (with AS), Anx and Dp levels were higher than in Wistars (without AS), while in "4" and "0" rats with the related genetic background but contrasting in AS severity, Anx and Dp indices were not different. Fluoxetine treatment exerted antidepressant effect in all rat lines irrespective of its effect on AS. Thus, phenotypic expression of AS is not directly associated with the mechanisms of Anx and Dp development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27193875     DOI: 10.1134/S0012496616020058

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  13 in total

Review 1.  The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].

Authors:  Karine Sarkisova; Gilles van Luijtelaar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-17       Impact factor: 5.067

2.  Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures.

Authors:  K Yu Sarkisova; M A Kulikov
Journal:  Behav Brain Res       Date:  2005-09-23       Impact factor: 3.332

3.  Convulsive and nonconvulsive epilepsy in rats: effects on behavioral response to novelty stress.

Authors:  I S Midzyanovskaya; A B Shatskova; K Yu Sarkisova; G van Luijtelaar; L Tuomisto; G D Kuznetsova
Journal:  Epilepsy Behav       Date:  2005-04-26       Impact factor: 2.937

4.  Relation between startle reactivity and sucrose avidity in two rat strains bred for differential seizure susceptibility.

Authors:  Dwayne Runke; Dan C McIntyre; Veronique St-Onge; Krista L Gilby
Journal:  Exp Neurol       Date:  2011-02-12       Impact factor: 5.330

5.  Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation.

Authors:  Nigel C Jones; Michael R Salzberg; Gaurav Kumar; Abbie Couper; Margaret J Morris; Terence J O'Brien
Journal:  Exp Neurol       Date:  2007-10-05       Impact factor: 5.330

Review 6.  Channelopathies in idiopathic epilepsy.

Authors:  Sarah E Heron; Ingrid E Scheffer; Samuel F Berkovic; Leanne M Dibbens; John C Mulley
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 7.  Therapeutic potential of fluoxetine in neurological disorders.

Authors:  Jop P Mostert; Marcus W Koch; Marco Heerings; Dorothea J Heersema; Jacques De Keyser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  [Laboratory rat selection for the trait "the absence of audiogenic seizure proneness"].

Authors:  I B Fedotova; Z A Kostyna; N M Surina; I I Poletaeva
Journal:  Genetika       Date:  2012-06

9.  Different emotional disturbances in two experimental models of temporal lobe epilepsy in rats.

Authors:  Marion Inostroza; Elena Cid; Liset Menendez de la Prida; Carmen Sandi
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

10.  Depressogenic medications and other risk factors for depression among Polish patients with epilepsy.

Authors:  Magdalena Bosak; Wojciech Turaj; Dominika Dudek; Marcin Siwek; Andrzej Szczudlik
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-30       Impact factor: 2.570

View more
  2 in total

Review 1.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

2.  Clinical Study on Electronic Medical Neuroelectric Stimulation Based on the Internet of Things to Treat Epilepsy Patients with Anxiety and Depression.

Authors:  Bo Zhang; Weijie Wang; Shenguo Wang; Shaoping Li; Mingchao Liu; Lantian Wang; Caijun Yang
Journal:  J Healthc Eng       Date:  2021-03-17       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.